Conditional disease-free survival after surgical resection of Gastrointestinal stromal tumors a multi-institutional analysis of 502 patients

JAMA Surgery

Volumn 150, Issue 4, 2015, Pages 299-306

  Bischof, Danielle A ^a   Kim, Yuhree ^a   Dodson, Rebecca ^a   Jimenez, M Carolina ^b,c   Behman, Ramy ^c,d   Cocieru, Andrei ^e   Fisher, Sarah B ^f   Groeschl, Ryan T ^g   Squires, Malcolm H ^f   Maithel, Shishir K ^f   Blazer, Dan G ^e   Kooby, David A ^f   Gamblin, T Clark ^g   Bauer, Todd W ^h   Quereshy, Fayez A ^b,c   Karanicolas, Paul J ^c,d   Law, Calvin H L ^c,d   Pawlik, Timothy M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^e DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g MEDICAL COLLEGE OF WISCONSIN   (United States)

^h UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANADA; CANCER CENTER; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; COHORT ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; GASTROINTESTINAL STROMAL TUMOR; GASTROINTESTINAL SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NATIONAL HEALTH ORGANIZATION; NOMOGRAM; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; RECURRENCE RISK; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCORING SYSTEM; TUMOR VOLUME; UNITED STATES; CLINICAL TRIAL; GASTROINTESTINAL STROMAL TUMORS; MULTICENTER STUDY; PROGNOSIS; RISK; STOMACH NEOPLASMS; SURVIVAL; TREATMENT OUTCOME; TUMOR RECURRENCE;

CANADA; DISEASE-FREE SURVIVAL; FEMALE; GASTROINTESTINAL STROMAL TUMORS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETROSPECTIVE STUDIES; RISK; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UNITED STATES;

EID: 84928106572     PISSN: 21686254     EISSN: 21686262     Source Type: Journal    
DOI: 10.1001/jamasurg.2014.2881     Document Type: Article

References (22)

1. Miettinen M, Lasota J. Gastrointestinal stromal tumors-definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch. 2001;438(1):1-12.
2. Nilsson B, Bümming P, Meis-Kindblom JM, et al. Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era: a population-based study inwestern Sweden. Cancer. 2005;103(4):821-829.
3. Tryggvason G, Gíslason HG, Magnússon MK, Jónasson JG. Gastrointestinal stromal tumors in Iceland, 1990-2003: the icelandic GIST study, a population-based incidence and pathologic risk stratification study. Int J Cancer. 2005;117(2):289-293.
4. National Comprehensive Cancer Network. Von Mehren MG, Meyer C, Riedel R, Van Tine B. Soft tissue sarcoma. In: NCCN Clinical Practice Guidelines in Oncology. 2013. http://www.nccn.org/professionals/default.aspx. Accessed 2013.
5. Dematteo RP, Gold JS, Saran L, et al. Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST). Cancer. 2008;112(3):608-615.
6. Joensuu H. Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Hum Pathol. 2008;39(10):1411-1419.
7. Miettinen M, Makhlouf H, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up. Am J Surg Pathol. 2006;30(4):477-489.
8. Miettinen M, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol. 2005;29(1):52-68.
9. Fletcher CD, Berman JJ, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol. 2002;33(5):459-465.
10. Gold JS, Gönen M, Gutiérrez A, et al. Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis. Lancet Oncol. 2009;10(11):1045-1052.
11. American Joint Committee on Cancer. Cancer Staging Atlas: A Companion to the Seventh Editions of the AJCC Cancer Staging Manual and Handbook. 2nd ed. New York, NY: Springer; 2012.
12. Merrill RM, Henson DE, Ries LA. Conditional survival estimates in 34, 963 patients with invasive carcinoma of the colon. Dis Colon Rectum. 1998;41(9):1097-1106.
13. Henson DE, Ries LA, Carriaga MT. Conditional survival of 56, 268 patients with breast cancer. Cancer. 1995;76(2):237-242.
14. Nathan H, De Jong MC, Pulitano C, et al. Conditional survival after surgical resection of colorectal liver metastasis: an international multi-institutional analysis of 949 patients. J Am Coll Surg. 2010;210(5):755-764, 764-766.
15. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J AmStat Assoc. 1958;53(282):457-481.
16. Cox DR. Regression models and life-tables. J RStat Soc B. 1972;34(2):187-220.
17. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15(4):361-387.
18. Bouvier AM, Remontet L, Hédelin G, et al; Association of the French Cancer Registries (FRANCIM). Conditional relative survival of cancer patients and conditional probability of death: a French national database analysis. Cancer. 2009;115(19):4616-4624.
19. Joensuu H, Vehtari A, Riihimäki J, et al. Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts. Lancet Oncol. 2012;13(3):265-274.
20. Mayo SC, Nathan H, Cameron JL, et al. Conditional survival in patients with pancreatic ductal adenocarcinoma resected with curative intent. Cancer. 2012;118(10):2674-2681.
21. Choi M, Fuller CD, Thomas CR Jr, Wang SJ. Conditional survival in ovarian cancer: results from the SEER dataset 1988-2001. Gynecol Oncol. 2008;109(2):203-209.
22. Kato I, Severson RK, Schwartz AG. Conditional median survival of patients with advanced carcinoma: surveillance, epidemiology, and end results data. Cancer. 2001;92(8):2211-2219.